Detalhe da pesquisa
1.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931632
2.
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Oncologist
; 27(3): e286-e293, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274718
3.
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer.
Invest New Drugs
; 38(4): 1077-1084, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31506897
4.
A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study.
Invest New Drugs
; 38(4): 1137-1144, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707687
5.
A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies.
Invest New Drugs
; 38(5): 1442-1447, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32020438
6.
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).
Oncologist
; 24(11): 1439-1445, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420468
7.
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218.
Pediatr Blood Cancer
; 66(3): e27540, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393943
8.
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Lancet Oncol
; 18(3): e143-e152, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28271869
9.
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
N Engl J Med
; 368(12): 1101-10, 2013 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514287
10.
A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187.
Invest New Drugs
; 34(4): 450-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27075016
11.
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Cochrane Database Syst Rev
; (3): CD011430, 2015 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25730344
12.
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.
Lancet Oncol
; 15(12): 1379-88, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25439692
13.
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group.
JCO Precis Oncol
; 8: e2300687, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635935
14.
Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response.
Clin Cancer Res
; 29(1): 143-153, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302172
15.
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data.
Clin Lung Cancer
; 24(6): 528-540, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37438216
16.
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
J Thorac Oncol
; 18(6): 813-819, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841541
17.
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.
Invest New Drugs
; 30(2): 779-86, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21170669
18.
iRECIST and atypical patterns of response to immuno-oncology drugs.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715004
19.
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies.
Nat Commun
; 13(1): 3607, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750695
20.
Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients.
Transl Lung Cancer Res
; 10(2): 826-838, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718025